{{Rsnum
|rsid=3788200
|Gene=SLC19A1
|Chromosome=21
|position=45536657
|Orientation=plus
|GMAF=0.4881
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC19A1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 16.1 | 54.5 | 29.5
| HCB | 24.8 | 47.4 | 27.7
| JPT | 30.1 | 46.9 | 23.0
| YRI | 38.8 | 44.9 | 16.3
| ASW | 12.3 | 56.1 | 31.6
| CHB | 24.8 | 47.4 | 27.7
| CHD | 18.3 | 54.1 | 27.5
| GIH | 11.9 | 47.5 | 40.6
| LWK | 42.7 | 42.7 | 14.5
| MEX | 15.5 | 37.9 | 46.6
| MKK | 45.8 | 41.9 | 12.3
| TSI | 19.6 | 41.2 | 39.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=20683905
|Title=Association of folate receptor (folr1, folr2, folr3) and reduced folate carrier (slc19a1) genes with meningomyelocele
|OA=1
}}

{{PMID Auto
|PMID=25124723
|Title=SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms As Predictors Of Methotrexate-Related Toxicity In Portuguese Rheumatoid Arthritis Patients
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}